These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 2190525)
1. The fate of soluble steroids within breast prostheses in humans. Morykwas MJ; Argenta LC; Oneal RM; Kaiser DG Ann Plast Surg; 1990 May; 24(5):427-30. PubMed ID: 2190525 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of methylprednisolone sodium succinate and methylprednisolone in patients undergoing cardiopulmonary bypass. Kong AN; Jungbluth GL; Pasko MT; Beam TR; Jusko WJ Pharmacotherapy; 1990; 10(1):29-34. PubMed ID: 2179900 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of methylprednisolone hemisuccinate and methylprednisolone in chronic liver disease. Ludwig EA; Kong AN; Camara DS; Jusko WJ J Clin Pharmacol; 1993 Sep; 33(9):805-10. PubMed ID: 8227476 [TBL] [Abstract][Full Text] [Related]
4. Late side effects related to inflatable breast prostheses containing soluble steroids. Oneal RM; Argenta LC Plast Reconstr Surg; 1982 Apr; 69(4):641-5. PubMed ID: 7041149 [TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetics of methylprednisolone in accident victims with spinal cord injury. Barth J; Winkler J; Schumann R; Nagaraja NV; Madabushi R; Balbach S; Derendorf H; Möllmann H; Möllenhoff G Int J Clin Pharmacol Ther; 2004 Sep; 42(9):504-11. PubMed ID: 15487809 [TBL] [Abstract][Full Text] [Related]
6. Rate of diffusion of Solu-Medrol across the silastic membranes of breast prostheses-an in vitro study. Cucin RL; Guthrie RH; Graham M Ann Plast Surg; 1982 Sep; 9(3):228-9. PubMed ID: 6753698 [TBL] [Abstract][Full Text] [Related]
7. The use of soluble steroids within inflatable breast prostheses. Perrin ER Plast Reconstr Surg; 1976 Feb; 57(2):163-6. PubMed ID: 1250886 [TBL] [Abstract][Full Text] [Related]
8. On the use of soluble steroid within inflatable breast prostheses. Plast Reconstr Surg; 1978 Jul; 62(1):105-7. PubMed ID: 662957 [No Abstract] [Full Text] [Related]
9. Steroid and benzyl alcohol diffusion through tissue expanders and double lumen breast implants. Berman DE; Lettieri J; Herold DA; Lin YF; Morgan RF Ann Plast Surg; 1991 Oct; 27(4):316-20. PubMed ID: 1663323 [TBL] [Abstract][Full Text] [Related]
10. Comparative pharmacokinetics of methylprednisolone phosphate and hemisuccinate in high doses. Möllmann H; Rohdewald P; Barth J; Möllmann C; Verho M; Derendorf H Pharm Res; 1988 Aug; 5(8):509-13. PubMed ID: 3072558 [TBL] [Abstract][Full Text] [Related]
11. The injection-adjustable mammary implant. O'Keeffe PJ Ann Plast Surg; 1983 Sep; 11(3):237-41. PubMed ID: 6357032 [TBL] [Abstract][Full Text] [Related]
12. Methylprednisolone-hemisuccinate and its metabolites in serum, urine and bile from two patients with acute graft rejection. Lawson GJ; Chakraborty J; Tredger JM; Baylis EM Br J Clin Pharmacol; 1995 Feb; 39(2):176-8. PubMed ID: 7742157 [TBL] [Abstract][Full Text] [Related]
13. A comparative population pharmacokinetic analysis for methylprednisolone following multiple dosing of two prodrugs in patients with acute asthma. Parker TJ; Daley-Yates PT; Wood SA Br J Clin Pharmacol; 1997 Jun; 43(6):589-92. PubMed ID: 9205818 [TBL] [Abstract][Full Text] [Related]
14. High-performance liquid chromatographic determination of hydrocortisone and methylprednisolone and their hemisuccinate esters in human serum. Smith MD J Chromatogr; 1979 Oct; 164(2):129-37. PubMed ID: 541404 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic and pharmacodynamic assessment of bioavailability for two prodrugs of methylprednisolone. Daley-Yates PT; Gregory AJ; Brooks CD Br J Clin Pharmacol; 1997 Jun; 43(6):593-601. PubMed ID: 9205819 [TBL] [Abstract][Full Text] [Related]
16. The various etiological factors of "hard capsule" formation in breast augmentations. Ferreira JA Aesthetic Plast Surg; 1984; 8(2):109-17. PubMed ID: 6464835 [TBL] [Abstract][Full Text] [Related]
17. Methylprednisolone hemisuccinate and metabolites in urine from patients receiving high-dose corticosteroid therapy. Lawson GJ; Chakraborty J; Dumasia MC; Baylis EM Ther Drug Monit; 1992 Feb; 14(1):20-6. PubMed ID: 1546386 [TBL] [Abstract][Full Text] [Related]
18. Simultaneous analysis of methylprednisolone hemisuccinate, cortisol and methylprednisolone by normal-phase high-performance liquid chromatography in human plasma. Kong AN; Slaughter RL; Jusko WJ J Chromatogr; 1988 Nov; 432():308-14. PubMed ID: 3065346 [No Abstract] [Full Text] [Related]
19. A new validated facile HPLC analysis method to determine methylprednisolone including its derivatives and practical application. Al-Hakkani MF Sci Rep; 2023 Jul; 13(1):11548. PubMed ID: 37460790 [TBL] [Abstract][Full Text] [Related]
20. Disposition of methylprednisolone and its sodium succinate prodrug in vivo and in perfused liver of rats: nonlinear and sequential first-pass elimination. Kong AN; Jusko WJ J Pharm Sci; 1991 May; 80(5):409-15. PubMed ID: 1880717 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]